Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127037541 | 12703754 | 1 | I | 20160615 | 20160831 | 20160831 | EXP | GB-JNJFOC-20160617507 | JANSSEN | 0.00 | A | F | Y | 0.00000 | 20160831 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127037541 | 12703754 | 1 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | U | U | UNKNOWN | 0 | 45 | MG | SOLUTION FOR INJECTION | |||||
| 127037541 | 12703754 | 2 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | U | U | UNKNOWN | 125261 | 45 | MG | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127037541 | 12703754 | 1 | Psoriasis |
| 127037541 | 12703754 | 2 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127037541 | 12703754 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127037541 | 12703754 | Cough | |
| 127037541 | 12703754 | Inappropriate schedule of drug administration | |
| 127037541 | 12703754 | Localised infection | |
| 127037541 | 12703754 | Off label use | |
| 127037541 | 12703754 | Psoriasis | |
| 127037541 | 12703754 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |